跳至主要内容
临床试验/NCT05632497
NCT05632497招募中不适用

Study of Translational Process of Relationship Between Intestinal Microbiota of Dysbiosis and the Psychic Symptoms of Anorexia Nervosa (Eating Disorders and Anxio-depression Disorders)

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年5月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
1
主要终点
Eating Disorder

研究概览

简要总结

The purpose of this study will be to study the association between the level of psychic symptomatic of anorexia nervosa (AN) (intensity of food restriction, symptoms of anxiety and depression) and alteration of host environment symbiosis and the mechanism (dysbiosis of intestinal microbiota, increase of intestinal permeability, immunity alteration and low-grade inflammation).

详细描述

This is a monocentric study aims to characterise the intestinal microbiota of anorexia nervosa patients with malnutrition, in comparison with the control subject, by DNA sequencing and metagenomic method. The interaction of intetinal microbiota with the host will be studied through the mecanistic studies and various parameters of alteration of symbiosis (intestinal permeability, inflammation) and their association with psychic symptoms of anorexia nervosa.

The objective of this approche is to have not only a descrition of genomic of material of sampling, but also an overview of its potential functioning.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For patients:
  • Patients aged ≥18 years;
  • Anorexia according to DSM-5 and CIDI (Composite International Diagnostic Interview);
  • Body mass index (BMI) (P/T2) < 15;
  • Hospitalization for nutrition rehabilitation;
  • Covered by a health insurance;
  • Informed consent form signed.
  • For Healthy Volunteers:
  • Aged ≥18 years;
  • 18.5 < BMI (P/T2) < 25;
  • Covered by a health insurance;
  • Informed consent form signed.

排除标准

  • For patients:
  • Patients no-responding all criteria of DSM-5 or CIDI scores;
  • Taken of antibiotic treatment 2 months / or laxativ 3 weeks before hospitalization;
  • Somatic comorbidity should perturb intestinal microbiota (Crohn's disease, diabetes and all other chronic inflammatory diseases);
  • Patients under guardianship;
  • Patients covered by french AME scheme.
  • For Healthy Volunteers:
  • Any disease should perturb intestinal microbiota;
  • Recent ponderal variation;
  • Taken of antibiotic treatment 2 months or laxativ 3 weeks before hospitalization;
  • Under guardianship;
  • Covered by french AME scheme.

研究组 & 干预措施

Anorexia patients

Hospitalized anorexia patients with body mass index < 15.

干预措施: Stool and blood samples (Biological)

Healthy controls

Health volunteers: 18 years or older with body mass index between 18.5 and 25.

干预措施: Stool and blood samples (Biological)

结局指标

主要结局

Eating Disorder

时间窗: at baseline

By Eating Disorder Inventory (EDI-3)

Anxio-depressive symptomatologic assessements by HAD score

时间窗: at baseline

By HAD score

Anxio-depressive symptomatologic assessements by LSAS Lieboweitz social anxiety scale

时间窗: at baseline

By LSAS Lieboweitz social anxiety scale

Anxio-depressive symptomatologic assessements

时间窗: at baseline

By HAD score, scale of Beck BDI 13, LSAS Lieboweitz social anxiety scale, Maudsley Obsessions and compulsions inventory (MOCI).

Physical exercise

时间窗: at baseline

By Global physical activity questionnaire (GPAQ)

Biological parameter

时间窗: at baseline

By serum serotonin level

Anxio-depressive symptomatologic assessements by scale of Beck BDI 13

时间窗: at baseline

By scale of Beck BDI 13

Anxio-depressive symptomatologic assessements by MOCI

时间窗: at baseline

By Maudsley Obsessions and compulsions inventory (MOCI).

次要结局

  • Immunity alteration(at baseline)
  • EDI(at baseline)
  • Gene and species richness(at baseline)
  • Circulating mitochondrial DNA copy number(at baseline)
  • Presence of Autistic symptoms (1)(at baseline)
  • Eating Disorder Diagnostic(at baseline)
  • Diversity indice(at baseline)
  • Intestinal permeability(at baseline)
  • Liver function(at baseline)
  • BMI(at baseline)
  • Body composition(at baseline)
  • Intestinal functional disorders(at baseline)
  • Energy expenditure(at baseline)
  • Heart damage(at baseline)
  • Presence of Autistic symptoms (2)(at baseline)
  • Eating behaviors assessment(at baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验